- Home
- BFST vs BLFS Comparison
BFST vs BLFS Comparison
Compare BFST & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | BLFS |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | 842 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.1M | 923.5M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BFST | BLFS |
|---|---|---|
| Price | $26.78 | $20.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $32.75 | $32.00 |
| AVG Volume (30 Days) | 136.2K | ★ 328.6K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | 23.45 | ★ 77.27 |
| EPS | ★ 0.68 | 0.02 |
| Revenue | $10,704,000.00 | ★ $96,214,000.00 |
| Revenue This Year | $22.71 | $19.73 |
| Revenue Next Year | $5.02 | $17.82 |
| P/E Ratio | ★ $39.88 | $1,049.50 |
| Revenue Growth | 1.20 | ★ 16.97 |
| 52 Week Low | $22.56 | $17.86 |
| 52 Week High | $30.32 | $29.57 |
Technical Indicators
Market Signals| Indicator | BFST | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.44 | 43.77 |
| Support Level | $26.78 | $19.71 |
| Resistance Level | $28.18 | $20.47 |
| Average True Range (ATR) | 0.54 | 0.95 |
| MACD | -0.09 | -0.15 |
| Stochastic Oscillator | 15.08 | 17.85 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.